Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Sponsor: Definium Therapeutics US, Inc.
Summary
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Ascend
Official title: A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults With Major Depressive Disorder - Ascend
Key Details
Gender
All
Age Range
18 Years - 74 Years
Study Type
INTERVENTIONAL
Enrollment
165
Start Date
2026-05-10
Completion Date
2028-06
Last Updated
2026-05-27
Healthy Volunteers
No
Conditions
Interventions
Placebo
A substance that is designed to have no therapeutic value
DT120
A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A)
Locations (27)
Lighthouse Psychiatry
Gilbert, Arizona, United States
Preferred Research Partners, Inc.
Little Rock, Arkansas, United States
Kadima Neuropsychiatry Institute
San Diego, California, United States
UCSF Department of Neurology
San Francisco, California, United States
Psychedelic Science Institute
Santa Monica, California, United States
Mountain View Clinical Research, Inc
Denver, Colorado, United States
K2 Medical Research (Maitland)
Maitland, Florida, United States
Charter Research
Orlando, Florida, United States
K2 Medical Research (Tampa)
Tampa, Florida, United States
CenExel Atlanta
Atlanta, Georgia, United States
CenExel Decatur
Decatur, Georgia, United States
CenExel Savannah
Savannah, Georgia, United States
Uptown Research Institute
Chicago, Illinois, United States
Adams Clinical Boston
Boston, Massachusetts, United States
Adams Clinical
Boston, Massachusetts, United States
Vitalix Clinical
Worcester, Massachusetts, United States
Arch Clinical Trials, LLC
St Louis, Missouri, United States
Redbird Research
Las Vegas, Nevada, United States
Adams Clinical Harlem
New York, New York, United States
Cleveland Clinic
Cleveland, Ohio, United States
Adams Clinical Philadelphia
Philadelphia, Pennsylvania, United States
Coastal Carolina Research
North Charleston, South Carolina, United States
Austin Clinical Trial Partners
Austin, Texas, United States
Cedar Clinical Research
Draper, Utah, United States
Inner Space Research
Orem, Utah, United States
Seattle Neuropsychiatric Treatment Center
Seattle, Washington, United States
VA Portland Healthcare System
Vancouver, Washington, United States